Share
24,988 Posts.
lightbulb Created with Sketch. 985
clock Created with Sketch.
20/10/20
15:08
Share
Originally posted by rikki:
↑
Paxalisib it broadly recognised as remarkable Increasing efficacy by +60% on the current standard of care... in GBM the primary condition of focus Kazia identified a shelved molecule at the storied cancer drug development company, Genentech. In fact, Genentech has been so successful at therapeutic development, when Roche Holdings took them over, it chose to leave it completely intact so as not to destroy Genentech’s culture of success. Kazia felt there was a lot to like about the drug, named GDC-0084 at the time, and we concurred. Specifically: The science behind paxalisib was outstanding,
Expand
Rikki The market cap is down again today imo Dyor on treatments vs Cures Genentech sold it to the highest bidder over 4 years ago Risky Agree CR city -Cash Cow